HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B
- 31 March 1997
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 26 (3), 503-507
- https://doi.org/10.1016/s0168-8278(97)80414-x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Pathogenesis and efficacy of modulation of host response in hepatitis B and CCurrent Opinion in Infectious Diseases, 1994
- HLA DR–DQ associations with cervical carcinoma show papillomavirus–type specificityNature Genetics, 1994
- Clinical aspects of hepatitis B virus infectionThe Lancet, 1993
- The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequenceHuman Immunology, 1993
- Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donorsHepatology, 1993
- Rapid HLA‐DRB1 genotyping by nested PCR amplificationTissue Antigens, 1992
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991
- Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to Pre-S- and S-encoded viral surface antigensHepatology, 1991
- HLA antigens in patients with various courses after hepatitis B virus infectionHepatology, 1987
- HLA-DR Antigens in HBsAg-Positive Chronic Active Liver Disease with and without Associated Delta InfectionHepatology, 1984